These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10601609)

  • 21. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma: a new era in the treatment of malignant brain tumours?
    Henriksson R; Bergström P; Johansson M; Sandström M
    Acta Oncol; 2009; 48(1):6-8. PubMed ID: 18932097
    [No Abstract]   [Full Text] [Related]  

  • 23. VEGF inhibitors in brain tumors.
    Brastianos PK; Batchelor TT
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):753-60, 768. PubMed ID: 20075834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of disseminated lymphangiomatosis with recombinant interferon therapy.
    Laverdière C; David M; Dubois J; Russo P; Hershon L; Lapierre JG
    Pediatr Pulmonol; 2000 Apr; 29(4):321-4. PubMed ID: 10738021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposiform hemangioendothelioma and therapy with interferon-alpha.
    Deb G
    Med Pediatr Oncol; 2003 Dec; 41(6):593. PubMed ID: 14595731
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multifocal epithelioid hemangioendothelioma with partial remission after interferon alfa-2a treatment].
    Roudier-Pujol C; Enjolras O; Lacronique J; Guillemette J; Herbreteau D; Leibowitch M; Escande JP
    Ann Dermatol Venereol; 1994; 121(12):898-904. PubMed ID: 7632008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
    Maddrey WC
    Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
    Blatt J; Stavas J; Moats-Staats B; Woosley J; Morrell DS
    Pediatr Blood Cancer; 2010 Dec; 55(7):1396-8. PubMed ID: 20730884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study.
    Abramovitch R; Itzik A; Harel H; Nagler A; Vlodavsky I; Siegal T
    Neoplasia; 2004; 6(5):480-9. PubMed ID: 15548356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Contribution of Angiogenesis to the Process of Metastasis.
    Bielenberg DR; Zetter BR
    Cancer J; 2015; 21(4):267-73. PubMed ID: 26222078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
    Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
    Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of avastin in the management of recurrent glioblastoma.
    Sweet JA; Feinberg ML; Sherman JH
    Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic therapies in glioblastoma multiforme.
    McNamara MG; Mason WP
    Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complete remission of lung and hepatic metastases from renal cell carcinoma by interferon alpha-2b therapy: a case report].
    Okaneya T; Murata Y; Kinebuchi Y
    Hinyokika Kiyo; 1999 Sep; 45(9):617-9. PubMed ID: 10540707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic therapy in the management of brain tumors: a clinical overview.
    Kunnakkat S; Mathew M; Narayana A
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):353-63. PubMed ID: 22825032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report.
    Piccaluga PP; Visani G; Isidori A; Malagola M; Ascani S; Pileri SA
    Leukemia; 2003 May; 17(5):986-7. PubMed ID: 12750719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.